Neural transmission is a communication between neurons and target cell
s, resulting in behavioral and physiological changes. Defective or alt
ered neural transmission is thought to occur in neuropsychiatric and n
eurodegenerative illnesses. To probe the biological consequences of de
fective or altered neural transmission, various genetically engineered
transgenic mouse models have been developed, together with convention
al pharmacological manipulation. Via genetic manipulation, we are able
to engineer specific neurotransmitters, receptors, inactivation of ne
urotransmitters or neural innervation density. Moreover, recently deve
loped molecular genetic techniques make it possible to induce either a
gene knock out event or transgene expression at a discrete time point
in a specific neuronal population in both embryos and adult animals.
In conjunction with pharmacological manipulation, these sophisticated
genetic manipulations of neural transmission will provide new tools to
control neural transmission in both normal and pathophysiological con
ditions.